---

Developing pharmacovigilance programs has become increasingly complex amid challenging economic conditions. This paper explores four key areas in which companies of all sizes can take steps to maintain quality and safety while making every dollar count.

Topics include:

• Early phase planning strategies
• Emerging data-management tactics
• Regulatory communication strategies
• Partnerships and managing outsourced vendors